JP2024102045A5 - - Google Patents
Info
- Publication number
- JP2024102045A5 JP2024102045A5 JP2024045217A JP2024045217A JP2024102045A5 JP 2024102045 A5 JP2024102045 A5 JP 2024102045A5 JP 2024045217 A JP2024045217 A JP 2024045217A JP 2024045217 A JP2024045217 A JP 2024045217A JP 2024102045 A5 JP2024102045 A5 JP 2024102045A5
- Authority
- JP
- Japan
- Prior art keywords
- patient
- gdc
- pharmaceutically acceptable
- administered
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063023501P | 2020-05-12 | 2020-05-12 | |
| US63/023,501 | 2020-05-12 | ||
| JP2022515505A JP2023500558A (ja) | 2020-05-12 | 2021-05-10 | Ｇｄｃ－９５４５及びｃｄｋ４／６阻害剤を含む併用療法を使用した乳がん治療 |
| PCT/US2021/031491 WO2021231250A1 (en) | 2020-05-12 | 2021-05-10 | Treatment of breast cancer using combination therapies comprising gdc-9545 and a cdk4/6 inhibitor |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022515505A Division JP2023500558A (ja) | 2020-05-12 | 2021-05-10 | Ｇｄｃ－９５４５及びｃｄｋ４／６阻害剤を含む併用療法を使用した乳がん治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024102045A JP2024102045A (ja) | 2024-07-30 |
| JP2024102045A5 true JP2024102045A5 (https=) | 2025-12-16 |
Family
ID=76250442
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022515505A Withdrawn JP2023500558A (ja) | 2020-05-12 | 2021-05-10 | Ｇｄｃ－９５４５及びｃｄｋ４／６阻害剤を含む併用療法を使用した乳がん治療 |
| JP2023132463A Pending JP2023175688A (ja) | 2020-05-12 | 2023-08-16 | Ｇｄｃ－９５４５及びｃｄｋ４／６阻害剤を含む併用療法を使用した乳がん治療 |
| JP2024045217A Pending JP2024102045A (ja) | 2020-05-12 | 2024-03-21 | Ｇｄｃ－９５４５及びｃｄｋ４／６阻害剤を含む併用療法を使用した乳がん治療 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022515505A Withdrawn JP2023500558A (ja) | 2020-05-12 | 2021-05-10 | Ｇｄｃ－９５４５及びｃｄｋ４／６阻害剤を含む併用療法を使用した乳がん治療 |
| JP2023132463A Pending JP2023175688A (ja) | 2020-05-12 | 2023-08-16 | Ｇｄｃ－９５４５及びｃｄｋ４／６阻害剤を含む併用療法を使用した乳がん治療 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11918561B2 (https=) |
| EP (1) | EP4149476A1 (https=) |
| JP (3) | JP2023500558A (https=) |
| KR (1) | KR20230009390A (https=) |
| CN (2) | CN115551513B (https=) |
| AU (1) | AU2021272100B2 (https=) |
| CA (1) | CA3182018A1 (https=) |
| IL (1) | IL298071A (https=) |
| MX (1) | MX2022014133A (https=) |
| TW (1) | TWI800827B (https=) |
| WO (1) | WO2021231250A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2023009374A (es) * | 2021-02-16 | 2023-08-16 | Genentech Inc | Tratamiento de cancer de mama mediante el uso de tratamientos conjuntos que comprenden gdc-9545 y abemaciclib o ribociclib. |
| IL315153A (en) * | 2022-03-14 | 2024-10-01 | Genentech Inc | Combined treatments for breast cancer |
| CN121337802B (zh) * | 2025-10-23 | 2026-04-14 | 安徽益普克医药科技发展有限公司 | 一种雌激素降解剂衍生物及其制备方法与用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102529049B1 (ko) * | 2013-08-14 | 2023-05-08 | 노파르티스 아게 | 암의 치료를 위한 조합 요법 |
| KR102358935B1 (ko) * | 2014-02-12 | 2022-02-04 | 가부시키가이샤 한도오따이 에네루기 켄큐쇼 | 전자 기기 |
| KR102785474B1 (ko) * | 2014-12-18 | 2025-03-26 | 에프. 호프만-라 로슈 아게 | 테트라하이드로-피리도[3,4-b]인돌 에스트로겐 수용체 조절제 및 이의 용도 |
| JP7019422B2 (ja) * | 2015-04-29 | 2022-02-15 | ラジウス ファーマシューティカルズ，インコーポレイテッド | 癌を治療するための方法 |
| KR20180119570A (ko) | 2016-03-15 | 2018-11-02 | 메리맥 파마슈티컬즈, 인크. | 항-ErbB3 항체를 포함하는 병용 요법을 이용한 ER+, HER2-, HRG+ 유방암의 치료 |
| LT3810283T (lt) * | 2018-06-21 | 2023-08-25 | F. Hoffmann-La Roche Ag | 3-((1r,3r)-1-(2,6-difluor-4-((1-(3-fluorpropil)azetidin-3- il)amino) fenil)-3-metil-1,3,4,9-tetrahidro-2h-pirido[3,4-b]indol-2-il)- 2,2- difluorpropan-1-olio tartrato druskos kietosios formos, jų paruošimo procesas ir jų naudojimo būdai vėžiui gydyti |
| CA3109090A1 (en) | 2018-08-17 | 2020-02-20 | F. Hoffmann-La Roche Ag | Diagnostic and therapeutic methods for the treatment of breast cancer |
| JP7826068B2 (ja) * | 2022-03-11 | 2026-03-09 | 本田技研工業株式会社 | パワーユニット、及びパワーユニットを搭載した作業機 |
-
2021
- 2021-05-10 TW TW110116831A patent/TWI800827B/zh active
- 2021-05-10 MX MX2022014133A patent/MX2022014133A/es unknown
- 2021-05-10 JP JP2022515505A patent/JP2023500558A/ja not_active Withdrawn
- 2021-05-10 CN CN202180034978.8A patent/CN115551513B/zh active Active
- 2021-05-10 KR KR1020227039518A patent/KR20230009390A/ko active Pending
- 2021-05-10 IL IL298071A patent/IL298071A/en unknown
- 2021-05-10 EP EP21729702.7A patent/EP4149476A1/en active Pending
- 2021-05-10 WO PCT/US2021/031491 patent/WO2021231250A1/en not_active Ceased
- 2021-05-10 CN CN202510482379.2A patent/CN120324434A/zh active Pending
- 2021-05-10 US US17/316,455 patent/US11918561B2/en active Active
- 2021-05-10 AU AU2021272100A patent/AU2021272100B2/en active Active
- 2021-05-10 CA CA3182018A patent/CA3182018A1/en active Pending
-
2023
- 2023-08-16 JP JP2023132463A patent/JP2023175688A/ja active Pending
-
2024
- 2024-01-26 US US18/423,596 patent/US12303495B2/en active Active
- 2024-03-21 JP JP2024045217A patent/JP2024102045A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024102045A5 (https=) | ||
| JP2023175688A5 (https=) | ||
| CN1103589C (zh) | 调节人体性反应的方法 | |
| US5470883A (en) | Method of treating peripheral vasoconstriction with tamoxifen citrate | |
| CN1152868A (zh) | 使用屈洛昔芬治疗前列腺疾病、子宫内膜异位和肥胖症 | |
| JP2019529581A5 (https=) | ||
| TW202333675A (zh) | 用於治療癌症之組合療法之用途 | |
| JP2019529574A5 (https=) | ||
| TW202304424A (zh) | 包含依維莫司和安森司群的組合 | |
| CN1512886A (zh) | 抗孕激素预防和治疗激素依赖性疾病的用途 | |
| CN1291889A (zh) | 氟西汀盐酸盐用于降低热潮红 | |
| JP2018123168A (ja) | 癌療法における使用のためのトランス−クロミフェン | |
| JP6743001B2 (ja) | シス−クロミフェンを用いたアンドロゲン除去療法によって生じるホットフラッシュ及び骨量減少の治療 | |
| CN1407890A (zh) | 牛皮癣的治疗 | |
| CN1929835A (zh) | 芳香酶抑制剂治疗－相关的骨质疏松症的治疗 | |
| JPWO2021030248A5 (https=) | ||
| CN101010074A (zh) | 选择性雌激素受体调节剂在制备用于治疗或预防雄激素缺乏的药物制剂中的用途 | |
| KR20150132888A (ko) | 파록세틴으로 체온 조절 기능 이상을 치료하는 방법 | |
| TW201244732A (en) | Ezatiostat for treating multiple myeloma | |
| US20040068000A1 (en) | Compression coated tablets | |
| JPWO2020037152A5 (https=) | ||
| JPH09506902A (ja) | 前立線癌の化学療法剤の補助剤 | |
| JPWO2023100070A5 (https=) | ||
| EP4681723A1 (en) | Pharmaceutical composition for treating triple-negative breast cancer | |
| JPWO2021026454A5 (https=) |